Pankovcin Corinne 4
4 · ADiTx Therapeutics, Inc. · Filed Nov 4, 2020
Insider Transaction Report
Form 4
Pankovcin Corinne
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-11-02+15,000→ 15,000 totalExercise: $1.92From: 2020-11-02Exp: 2030-11-02→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2020-11-02+165,000→ 165,000 totalExercise: $1.92Exp: 2030-11-02→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The options shall vest as to one-third (1/3) of the total shares on November 2, 2021, after which the remaining two-thirds (2/3) of the total shares shall vest in eight successive equal quarterly installments.